Teriparatide

Indications & Dose:

Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures | Treatment of corticosteroid-induced osteoporosis

• BY SUBCUTANEOUS INJECTION

Adult: 20 micrograms daily for maximum duration of treatment 24 months (course not to be repeated) 

Contraindications:

Hypersensitivity to teriparatide or its components 

Side Effects:

Cautions:

Precautions:

Interaction:

DRUGS

digitalis glycosides: Possibly increased risk of digitalis toxicity 

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

CNS: Asthenia, depression, dizziness, head-ache, insomnia, paresthesia, syncope, vertigo
CV: Angina pectoris, chest pain, hypertension, transient orthostatic hypotension
EENT: Pharyngitis, rhinitis, taste perversion, tooth disorder
ENDO: Transient hypoparathyroidism
GI: Constipation, diarrhea, indigestion, vomiting
MS: Arthralgia, muscle cramps or spasms in back or leg, neck pain
RESP: Cough, dyspnea, pneumonia
SKIN: Diaphoresis, pruritus, rash, urticaria
Other: Angioedema, generalized pain, injection-site reactions (erythema, localized bruising, minor bleeding, pain, pruritus, swelling), transient hypercalcemia or hypocalcemia

Patient And Carer Advice: